The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,724.00
Bid: 2,716.00
Ask: 2,718.00
Change: 8.00 (0.29%)
Spread: 2.00 (0.074%)
Open: 2,716.00
High: 2,734.00
Low: 2,710.00
Prev. Close: 2,716.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Mar 2024 17:55

RNS Number : 8114I
Coca-Cola HBC AG
28 March 2024

FOR IMMEDIATE RELEASE

28 March 2024

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that, as a result of the satisfaction of performance conditions, the award granted on 12 September 2023 which was due to vest in March 2024 under the Company's Performance Share Award Plan ("PSP") vested on 27 March 2024 and has been transferred to the PDMR from shares held in treasury.

The following sets out the award that vested on 27 March 2024 and the number of shares sold following such vesting to cover taxes and other liabilities.

PDMR

Number of shares granted under the PSP vesting

Number of dividend equivalent shares

Number of shares sold to cover taxes and other liabilities

EBRU OZGEN

7,038

0

375

The Notification of Dealing Forms for the PDMR can be found below.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

EBRU OZGEN

2

Reason for the notification

a)

Position/status

CHIEF PEOPLE AND CULTURE OFFICER

b)

Initial notification /Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

COCA-COLA HBC AG

b)

LEI

549300EFP3TNG7JGVE49

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

CH0198251305

b)

Nature of the transaction

SHARES ISSUED TO PDMR FOLLOWING VESTING OF PERFORMANCE SHARE AWARD GRANTED IN SEPTEMBER 2023 WHICH WAS DUE TO VEST IN MARCH 2024 UNDER THE TERMS OF THE PSP. SHARES ISSUED BY A TRANSFER FROM SHARES HELD IN TREASURY

c)

Price(s) and volume(s)

Price(s)

Volume(s)

25.18843 GBP

7,038

d)

Aggregated information

- Aggregated volume

- Price

Price

Volume

Total

25.18843 GBP

7,038

177,276.17 GBP

e)

Date of the transaction

27 MARCH 2024

f)

Place of the transaction

XLON

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

CH0198251305

b)

Nature of the transaction

SALE OF SHARES TO COVER TAX AND OTHER LIABILITIES ARISING FROM VESTING OF THE PERFORMANCE SHARE AWARD

c)

Price(s) and volume(s)

Price(s)

Volume(s)

25.18843 GBP

375

d)

Aggregated information

- Aggregated volume

- Price

Price

Volume

Total

25.18843 GBP

375

9,445.66 GBP

e)

Date of the transaction

27 MARCH 2024

f)

Place of the transaction

XLON

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQKFBPOBKDBNB
Date   Source Headline
15th Sep 20222:44 pmRNSHolding(s) in Company
15th Sep 20228:49 amRNSIssue of Debt
13th Sep 202212:38 pmRNSDirector/PDMR Shareholding
7th Sep 202212:05 pmRNSHolding(s) in Company
6th Sep 20222:03 pmRNSPublication of a Prospectus
30th Aug 20229:14 amRNSHolding(s) in Company
25th Aug 20229:01 amRNSHolding(s) in Company
23rd Aug 20221:45 pmRNSHolding(s) in Company
23rd Aug 202211:06 amRNSHolding(s) in Company
18th Aug 20223:43 pmRNSHolding(s) in Company
18th Aug 202212:05 pmRNSHolding(s) in Company
18th Aug 202211:24 amRNSDirector/PDMR Shareholding
11th Aug 202212:40 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSStrong volumes, revenue, EBIT; investing in growth
9th Aug 20221:45 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSCCH agrees to acquire Three Cents
19th Jul 202212:53 pmRNSDirector/PDMR Shareholding
19th Jul 202210:48 amRNSNotice of Results
22nd Jun 202210:45 amRNSHolding(s) in Company
21st Jun 20224:28 pmRNSResult of AGM
20th Jun 20222:38 pmRNSDirector/PDMR Shareholding
8th Jun 20221:02 pmRNSAthens Exchange trading date of ordinary shares
6th Jun 20229:32 amRNSHolding(s) in Company
1st Jun 202210:02 amRNSIssue of Equity
31st May 20225:17 pmRNSLetter to shareholders
19th May 20229:20 amRNSNotice of AGM
18th May 20223:05 pmRNSDirector/PDMR Shareholding
18th May 202212:24 pmRNSHolding(s) in Company
12th May 20227:00 amRNSStrong performance despite turbulent environment
3rd May 202210:22 amRNSIssue of equity and total voting rights
3rd May 202210:05 amRNSBlock listing Interim Review
29th Apr 20221:46 pmRNSHolding(s) in Company
20th Apr 20223:03 pmRNSDirector/PDMR Shareholding
19th Apr 202210:06 amRNSNotice of Results
12th Apr 20225:38 pmRNSMove to organic reporting
1st Apr 20223:58 pmRNSDirector/PDMR Shareholding
1st Apr 20223:47 pmRNSDirector/PDMR Shareholding
1st Apr 202211:46 amRNSIssue of equity and total voting rights
23rd Mar 202212:23 pmRNSAnnual Financial Report
18th Mar 20222:02 pmRNSDirector/PDMR Shareholding
16th Mar 20223:43 pmRNSDirector/PDMR Shareholding
16th Mar 202212:56 pmRNSDirector/PDMR Shareholding
14th Mar 202210:57 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSUkraine and Russia update
3rd Mar 20224:31 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSUkraine and Russia conflict update
22nd Feb 20227:00 amRNSSTRONG EXECUTION DRIVES GROWTH MOMENTUM
18th Feb 20222:45 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:57 amRNSNotice of Results
1st Feb 20228:20 amRNSIssue of equity and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.